Impact of different gonadotropin and GnRH agonist regimens on serum and follicular fluid hormone levels and folliculogenesis

References

• Filicori M. Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs 1994; 48: 41–58
   PubMed Web of Science ®Google Scholar
• Meldrum D. R., Chang R. J., Lu J., Vale W., Rivier J., Judd H. L. ‘Medical oophorectomy’ using a long-acting GnRH agonist: a possible new approach to the treatment of endometriosis. J. Clin. Endocrinol. Metab. 1982; 54: 1081–3
   PubMed Web of Science ®Google Scholar
• Filicori M., Hall D. A., Loughlin J. S., Rivier J., Vale W., Crowley W. F., Jr. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by an LHRH analogue. Am. J. Obstet. Gynecol. 1983; 147: 726–7
   PubMed Web of Science ®Google Scholar
• Filicori M., Flamigni C., Dellai P., Cognigni G., Michelacci L., Arnone R., Sambataro M., Falbo A. Treatment of anovulation with pulsatile GnRH: prognostic factors and clinical results in 600 cycles. J. Clin. Endocrinol. Metab. 1994; 79: 1215–20
   PubMed Web of Science ®Google Scholar
• Fraser H. M., Sandow J. Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumped-tailed Macaque monkey. J. Clin. Endocrinol. Metab. 1985; 60: 579–84
   PubMedGoogle Scholar
• Fleming R., Adam A. H., Barlow D. H., Black W. P., MacNaughton M. C., Coutts J. R. A new systematic treatment for infertile women with abnormal hormone profiles. Br. J. Obstet. Gynaecol. 1982; 89: 80–3
   PubMedGoogle Scholar
• Fleming R., Haxton M. J., Hamilton M. P. R., McCune G. S., Black W. P., MacNaughton M. C. Successful treatment of infertile women with oligomenorrhea using a combination of an LHRH agonist and exogenous gonadotropins. Br. J. Obstet. Gynaecol. 1985; 92: 369–73
   PubMedGoogle Scholar
• Dodson W. C., Hughes C. L., Whitesides D. B., Haney A. F. The effect of leuprolide acetate on ovulation induction with human menopausal gonadotropins in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 1987; 65: 95–100
   PubMed Web of Science ®Google Scholar
• Frydman R., Belaisch-Allart J., Parneix I., Forman R., Hazout A., Testart J. Comparison between flare up and down regulation effects of luteinizing hormone-releasing hormone agonists in an in vitro fertilization program. Fertil. Steril. 1988; 50: 471–5
   PubMed Web of Science ®Google Scholar
• Tummon I. S., Daniel S. A., Kaplan B. R., Nisker J. A., Yuzpe A. A. Randomized, prospective comparison of luteal leuprolide acetate and gonadotropins versus clomiphene citrate and gonadotropins in 408 first cycles of in vitro fertilization. Fertil. Steril. 1992; 58: 563–8
   PubMed Web of Science ®Google Scholar
• Chetkowski R. J., Rode R. A., Burruel V., Nass T. E. The effect of pituitary suppression and the women's age on embryo viability and uterine receptivity. Fertil. Steril. 1991; 56: 1095–103
   PubMedGoogle Scholar
• Chetkowski R. J., Kruse L. R., Nass T. E. Improved pregnancy outcome with the addition of leuprolide acetate to gonadotropins for in vitro fertilization. Fertil. Steril. 1989; 52: 250–5
   PubMed Web of Science ®Google Scholar
• Abdalla H. J., Ahuja K. K., Leonard T., et al. Comparative trial of luteinizing hormone-releasing hormone analog/human menopausal gonadotropin and clomiphene citrate/human menopausal gonadotropin in an assisted conception program. Fertil. Steril. 1990; 53: 473–8
   PubMed Web of Science ®Google Scholar
• Polson D. W., MacLaghlan V., Krapez J. A., Wood C., Healy D. L. A controlled study of gonadotropin-releasing hormone agonist (buserelin acetate) for folliculogenesis in routine in vitro fertilization patients. Fertil. Steril. 1991; 56: 509–14
   PubMedGoogle Scholar
• Hughes E. G., Fedorkow D. M., Daya S., Sagle M. A., Van de Koppel P., Collins J. A. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomised controlled trails. Fertil. Steril. 1992; 58: 888–96
   PubMed Web of Science ®Google Scholar
• Filicori M., Flamigni C., Cognigni G. E., Falbo A., Arnone R., Capelli M., Pavani A., Mandini M., Calderoni P., Brondelli L. Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil. Steril. 1996, in press
   PubMedGoogle Scholar
• Jacobson A., Galen D., Milani H., Weckstein L., Jacobson J. A novel superovulation regimen: three day gonadotropin-releasing hormone agonist with overlapping gonadotropin. Fertil. Steril. 1991; 56: 1169–72
   PubMedGoogle Scholar
• Ron-El R., Herman A., Golan A., Soffer Y., Nachum H., Caspi E. Ultrashort gonadotropin-releasing hormone agonist (GnRH-a) protocol in comparison with the long-acting GnRH-a protocol and menotropin alone. Fertil. Steril. 1992; 58: 1164–8
   PubMedGoogle Scholar
• Acharya U., Small J., Randall J., Hamilton M., Templeton A. Prospective study of short and long regimens of gonadotropin-releasing hormone agonists in in vitro fertilization program. Fertil. Steril. 1992; 57: 815–18
   PubMed Web of Science ®Google Scholar
• Cedars M. L., Surrey E., Hamilton F., Lapolt P., Meldrum D. R. Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil. Steril. 1990; 53: 627–31
   PubMed Web of Science ®Google Scholar
• Wooten Zelinski M.B., Hess D. L., Baughman W. L., Molskness T. A., Wolf D. P., Souffer R. L. Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function. J. Clin. Endocrinol. Metab. 1993; 76: 988–95
   PubMedGoogle Scholar
• Louvet J. P., Harman S. M., Schrieber J. R., Ross G. T. Evidence of a role of androgens in follicular maturation. Endocrinology 1975; 97: 366–72
   PubMed Web of Science ®Google Scholar
• Armstrong D. T., Siuda A., Opasky M. A., Candrasekhar Y. Bimodal effects of luteinizing hormone and role of androgens in modifying superovulatory responses of rats to infusion with purified porcine follicle-stimulating hormone. Biol. Reprod. 1989; 40: 54–62
   PubMedGoogle Scholar
• Hsueh A. J., Dahl K. D., Vaughan J., Tucker E., Rivier J., Bardin C. W., Vale W. Heterodimers and homodimers of inhibin subunits have different paracrine action in the modulation of luteinizing hormone stimulated androgen biosynthesis. Proc. Natl. Acad. Sci. USA 1987; 84: 5082–6
   PubMed Web of Science ®Google Scholar
• Forage R. G., Brown R. W., Oliver K. J., Atrache B. T., Devine P. L., Hudson G. C., Goss N. H. Immunization against an inhibin subunit produced by recombinant DNA techniques results in increased ovulation rate in sheep. J. Endocrinol. 1987; 114: R1–4
   Web of Science ®Google Scholar
• Porcu E., Filicori M., Dal Prato L., Fabbri R., Seracchioli R., Colombi C., Flamigni C. Comparison between depot leuprorelin and daily Buserelin in IVF. J. Assist. Reprod. Gen. 1995; 12: 14–18
   Google Scholar
• Skarin G., Nillius S. J., Wide L. Failure to induce early abortion by huge doses of a superactive LHRH agonist in women (1982). Contraception 1982; 26: 457–63
   PubMed Web of Science ®Google Scholar
• Wilshire G. B., Emmi A. M., Gagliardi C. C., Weiss G. Gonadotropin-releasing hormone agonist administration in early human pregnancy is associated with normal outcomes. Fertil. Steril. 1993; 60: 980–3
   PubMedGoogle Scholar
• Elefant E., Biour B., Blumberg-Tick J., Roux C., Thomas F. Administration of a gonadotropin-releasing hormone agonist during pregnancy: follow-up of 28 pregnancies exposed to triptoreline. Fertil. Steril. 1995; 63: 1111–13
   PubMed Web of Science ®Google Scholar
• Ron-El R., Lehat E., Golan A., Lerman M., Bukovsky I., Herman A. Development of children born after ovarian superovulation induced by long-acting gonadotropin-releasing hormone agonist and menotropins, and by in vitro fertilization. J. Pediatr. 1994; 125: 734–7
   PubMedGoogle Scholar